Cornerstone Therapeutics Inc. (CRTX) announced the appointment of Alastair McEwan as Chief Financial Officer effective November 6, 2012. McEwan is a pharmaceutical industry executive with more than 30 years experience. He has served in many senior management positions and on executive boards and Boards of Directors including those of Averion International and Inveresk Research. He is a previous chairman of the Cornerstone Board of Directors.
For comments and feedback: editorial@rttnews.com